Review
Open access
Sep 2026
Combined radioligand therapy and immunotherapy for cancer: research advances and translational challenges
Radioligand therapy (RLT) delivers therapeutic radionuclides to tumor-associated targets through specific targeting ligands and has demonstrated substantial clinical value in malignancies such as prostate cancer and neuroendocrine tumors. Beyond its direct induction of radiation-mediated tumor cell damage, RLT has attr...
Sen Wang, Shou-Jun Tang, Sheng-Jie Tang et al.
· Frontiers in Pharmacology · 0 citations